Retrogenix will present and exhibit at the upcoming Essential Protein Engineering Summit (PEGS).
“Identifying critical immunotherapy target receptors and assessing target specificity using cell microarray technology”
Alex Kelly will present case studies that demonstrate the utility of the cell microarray technology in identifying novel immunotherapy targets as well as in specificity screening for biotherapeutics to aid safety assessment and provide key data to support IND submissions.
Members of the Retrogenix team will be available throughout the event and welcome questions from delegates.
For further information, please visit the conference website.